Octrizole

Octrizole

SCHEMBL5547097

CC(C)(C)CC(C)(C)c1ccc(O)c(-n2nc3ccccc3n2)c1.CC(C)(C)c1ccc(O)c(-n2nc3ccccc3n2)c1

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.52
RAB9A P51151 3/20 0.52
LMNA P02545 2/20 0.52
CYP2D6 P10635 3/20 0.41
CYP3A4 P08684 2/20 0.41
HIF1A Q16665 1/20 0.41
SHBG P04278 1/20 0.40
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
MAPT P10636 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
USP2 O75604 1/20 0.38
ESR1 P03372 1/20 0.38
TP53 P04637 1/20 0.38
PGR P06401 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
AR P10275 1/20 0.38
DRD1 P21728 1/20 0.38
PTGS1 P23219 1/20 0.38
SLC6A2 P23975 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Octrizole SCHEMBL29349945 0.96 NPC1 (0.56) NPC1RAB9ALMNACYP2D6CYP3A4
Octrizole SCHEMBL15508 0.96 NPC1 (0.56) NPC1RAB9ALMNACYP2D6CYP3A4
Octrizole SCHEMBL28983126 0.96 NPC1 (0.56) NPC1RAB9ALMNACYP2D6CYP3A4
Octrizole SCHEMBL30315837 0.95 NPC1 (0.55) NPC1RAB9ALMNACYP2D6CYP3A4
Octrizole SCHEMBL8614902 0.91 NPC1 (0.51) NPC1RAB9ALMNACYP2D6CYP3A4
Octrizole SCHEMBL12076352 0.90 NPC1 (0.68) NPC1RAB9ALMNACYP2D6CYP3A4
SCHEMBL78159 0.89 NPC1 (0.64) NPC1RAB9ALMNACYP2D6MEN1
SCHEMBL29354646 0.89 NPC1 (0.64) NPC1RAB9ALMNACYP2D6MEN1
SCHEMBL8390136 0.89 NPC1 (0.49) NPC1RAB9ALMNACYP2D6CYP3A4
Octrizole SCHEMBL5072028 0.86 NPC1 (0.46) NPC1RAB9ALMNACYP2D6CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2505323-B1 Composition for treating wood BERKEM SA (FR) 2014-02-26 EP disclosed
EP-2505323-A1 Composition for treating wood Berkem (FR) 2012-10-03 EP disclosed
EP-1765878-A1 PROCESS FOR PHOTOCURING WITH LIGHT EMITTING DIODES CIBA SPECIALTY CHEMICALS HOLDING INC. Patent Departement (CH) 2007-03-28 EP disclosed
WO-2005100408-A1 PROCESS FOR PHOTOCURING WITH LIGHT EMITTING DIODES CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2005-10-27 WO disclosed
US-6586606-B2 By hydrolyzing the corresponding 2-aminobenzofuran; use as stabilizer against oxidative, thermal, or light-induced degradation in lubricants, fuels, polymers, and hydraulic or metal working fluids CIBA SPECIALTY CHEMICALS CORPORATION 2003-07-01 US disclosed
US-20020115855-A1 Process for the preparation of 3-aryl-benzofuran-2-ones CIBA SPECIALTY CHEMICALS CORP. 2002-08-22 US disclosed
US-20020087000-A1 Oligomeric hindered amine light stabilizers based on multi-functional carbonyl compounds and methods of making same CYTEC TECHNOLOGY CORP. 2002-07-04 US disclosed
US-5616637-A PHOTOSTABILITY; OXIDTION AND HEAT RESISTANT CIBA-GEIGY CORPORATION (US) 1997-04-01 US disclosed
US-5614572-A Benzofuran-2-ones as stabilizers CIBA-GEIGY CORPORATION (US) 1997-03-25 US disclosed
US-5478875-A Reaction product of glycols or alcohols with vegetable oil and aromatic alcohol ester derivative; used in lubricants and polymers CIBA-GEIGY CORPORATION (US) 1995-12-26 US disclosed
US-5463058-A Light, heat and oxidation stabilizers for synthetic polymers CIBA-GEIGY CORPORATION (US) 1995-10-31 US disclosed
US-5442067-A Photostability, heat resistance, oxidation resistance CIBA-GEIGY CORPORATION (US) 1995-08-15 US disclosed
US-5405891-A Hindered amine light stabilizers CIBA-GEIGY CORPORATION (US) 1995-04-11 US disclosed
US-5369159-A Heat, oxidation and radiation resistance for polymers CIBA-GEIGY CORPORATION (US) 1994-11-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020115855-A1 Process for the preparation of 3-aryl-benzofuran-2-ones CYP1B1, CYP1A1, SULT1A1 NPC1 3095/4885RAB9A 4232/4885LMNA 1505/4885
US-20020087000-A1 Oligomeric hindered amine light stabilizers based on multi-functional carbonyl compounds and methods of making same CBR1, CCNE2, NAF1 NPC1 1993/4885RAB9A 2137/4885LMNA 748/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.